Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -5.39 |
| peg ratio | 0.03 |
| price to book ratio | 2.45 |
| price to sales ratio | 31.92 |
| enterprise value multiple | -5.90 |
| price fair value | 2.45 |
profitability ratios | |
|---|---|
| gross profit margin | 72.83% |
| operating profit margin | -700.61% |
| pretax profit margin | -629.86% |
| net profit margin | -629.86% |
| return on assets | -35.95% |
| return on equity | -54.45% |
| return on capital employed | -48.18% |
liquidity ratio | |
|---|---|
| current ratio | 5.09 |
| quick ratio | 5.08 |
| cash ratio | 3.01 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 6.02 |
| operating cycle | 21.08 |
| days of payables outstanding | 199.39 |
| cash conversion cycle | -178.31 |
| receivables turnover | 24.23 |
| payables turnover | 1.83 |
| inventory turnover | 60.65 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | -13.47 |
| cash flow to debt ratio | -36.69 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.50 |
| cash per share | 4.25 |
| operating cash flow per share | -1.50 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -36.69 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -216.17 |
Frequently Asked Questions
Stoke Therapeutics, Inc. (STOK) published its most recent earnings results on 05-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Stoke Therapeutics, Inc. (NASDAQ:STOK)'s trailing twelve months ROE is -54.45%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Stoke Therapeutics, Inc. (STOK) currently has a ROA of -35.95%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
STOK reported a profit margin of -629.86% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.09 in the most recent quarter. The quick ratio stood at 5.08, with a Debt/Eq ratio of 0.01.